Purchase and successive delivery of reagents for the GENEXUS device for the Molecular Diagnostics Department

This tender concerns the procurement and subsequent delivery of reagents specifically designed for the GENEXUS device, intended for use by the Molecular Diagnostics Department. The contracting authority is seeking a supplier capable of providing a consistent and reliable supply of these essential diagnostic materials. The procurement is not divided into lots, meaning interested parties must bid on the entire scope of work. Detailed specifications regarding the required assortment of reagents are provided within each of the assortment and price forms, which are attached as Annex No. 2 to the Specification of the Contract Requirements (SWZ). Potential bidders are advised to carefully review these specifications to ensure their offer fully meets the technical and quality standards expected by the Molecular Diagnostics Department. The successful bidder will be responsible for the timely and successive delivery of these reagents, ensuring the uninterrupted operation of the GENEXUS device and the continuity of diagnostic services. This contract is crucial for maintaining the diagnostic capabilities of the department, emphasizing the need for high-quality products and dependable logistics.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Laboratory. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.